Pay in 4 interest-free payments of $24.00 Learn more
Ships within 48 hours · Estimated delivery Sep 13 - Sep 18
Epivir HBV
Debio-1452
31)32)2-5-16(17)39-10-12-3-4-14(21(24
Abstract PR04: CPI-444: A potent and selective inhibitor of A2AR induces antitumor responses alone and in combination with anti-PD-L1 in preclinical and clinical studies
AN-2728 - CAS# 906673-24-3 Catalog No.:M10493-2 Epivir HBVCrisaborole, also known as AN 2728, is a topically administered, boron containing, anti inflammatory compound that inhibits PDE4 activity and thereby suppresses the release of TNFalpha, IL 12, IL 23 and other cytokines. At the time of publication, three phase Ib clinical trials, a IIa trial and a IIb trial of AN 2728 in patients with psoriasis had been completed; the compound was also undergoing phase II development for atopic dermatitis, but no data